iiCON is seeking suppliers to help build its Category Three, AI, Robotic Laboratories

iiCON is excited to announce the launch of a procurement tender to seek expressions of interest to develop the Category Three robotic laboratories, which will be capable of handling a variety of dangerous and deadly pathogens.

Government funding has been awarded to iiCON as part of the Liverpool City Region Life Sciences Investment Zone plans. This initiative aims to boost the sector and establish the labs which will be based at The Liverpool School of Tropical Medicine (LSTM). The labs will be kitted out with state of the art robotics, AI and liquid handling equipment.

iiCON’s vision and development of the new £10 million Robotic AI Laboratories include:

Revolutionising Research with Organoid Technology
Human organoid research is leading the way in developing innovative methods to combat deadly infections. Together with iiCON’s consortium lead, the Liverpool School of Tropical Medicine (LSTM), a cutting-edge containment level 3 organoid facility is being developed. This multidisciplinary team of biologists, chemists, and engineers will be dedicated to enhancing organoid platform capabilities.

State-of-the-Art Automation and AI
Equipped with advanced automation and AI tools, this facility will empower researchers and commercial partners to efficiently generate organoids and study their interactions with pathogens and new drug candidates. This acceleration in research processes will play a crucial role in developing innovative treatments, paving the way for breakthroughs that can save lives.

Strengthening Local and Global Impact
In partnership with the Liverpool City Region and the Investment Zone, iiCON are not only enhancing their research capabilities but also fostering community engagement and economic development. This initiative will create jobs, stimulate the local economy, and expand their collaborative network, making this specialised resource accessible to a broader range of companies, both nationally and internationally.

Making a Difference Through Collaboration
With this new robotic AI laboratory and the ground breaking organoid facility, iiCON are ushering in a new era of medical advancements. Innovating together to accelerate the creation of new treatments and products that can change lives, will help to drive impactful change in the field of infection research.

Opportunities
As we embark on this transformative journey, we invite collaborators to join us. If you’re already working in an aligned area and are interested in collaboration to get in touch, and if you’re a supplier and interested in being part of this innovative project, please register your interest for our procurement tender here. Your expertise can help shape the future of infection research and contribute to meaningful advancements in public health.